![Michael Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 30/06/2026
Michael J.
Yang is currently an Independent Director at Ionis Pharmaceuticals, Inc. and Pacira Biosciences, Inc., both since 2023, and an Operating Partner at ARTIS Ventures Management LP.
Former roles include President, Chief Executive Officer & Director at ViaCyte, Inc. (2021–2022); Director at Akcea Therapeutics, Inc. (2020); President at Johnson & Johnson; Chief Commercial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. (2017–2021); Vice President-Sales & Marketing at Ortho Biotech, Inc.; General Manager at Veridex LLC and Therakos LLC; President at Janssen Biotech, Inc.; and President-Immunology at Janssen Pharmaceuticals, Inc. (2013–2017).
Education includes undergraduate studies at San Diego State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/07/2026 | 7.940 ( 0% ) | 629 563 $ | 30/06/2026 | |
| 10/06/2026 | 19.798 ( 0,05% ) | 502 275 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 10/10/2023 |
| IONIS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 14/12/2023 |
ARTIS Ventures Management LP
 ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Investitore di Private Equity | - |
| Società | Posizione | Fine |
|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Amministratore Delegato | 01/10/2022 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 29/01/2021 |
| AKCEA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/12/2020 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/03/2017 |
| JOHNSON & JOHNSON | Presidente | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Ortho Biotech, Inc. | |
Veridex LLC
 Veridex LLC Medical SpecialtiesHealth Technology Supplies vitro diagnostic oncology products | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therakos, Inc.
 Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Finance |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
